Press release
AI-Based Clinical Trial Solution Market Predicted to Garner Revenue of USD 5.55 Bn at a CAGR of +19% by 2030 | Aicure, Antidote, Deep Lens, Saama Technologies
AI-Based Clinical Trial Solution Market
The AI-Based Clinical Trial Solution market which was USD 1.3 billion in 2022, would rocket up to USD 5.55 billion by 2030 and is expected to undergo a CAGR of +19% during the forecast period 2023 to 2030.
GMV published a new research publication on "AI-Based Clinical Trial Solution Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, and Opportunities generated by targeting market-associated stakeholders. The growth of the AI-Based Clinical Trial Solution market was mainly driven by the increasing R&D spending across the world.
Get a Free Sample Copy of Report @
https://globalmarketvision.com/sample_request/204771
Top Companies of AI-Based Clinical Trial Solution Market: -
Aicure, Antidote, Deep Lens, Saama Technologies, Trials.Ai, Deep 6 Ai, Innoplexus, Median Technologies, Mendel.Ai, Phesi, Deloitte, Innoplexus, Ibm
AI-Based Clinical Trial Solution Market On the basis of Type:
• Artificial Narrow Intelligence
• Artificial General Intelligence
• Artificial Super Intelligence
AI-Based Clinical Trial Solution Market by Application:
• Drug Discovery
• Drug Manufacturing
• Drug Marketing
• Diagnosis And Treatment
• Clinical Trials
Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa
Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
Key Benefits for Stakeholders:
1. The study represents a quantitative analysis of the present AI-Based Clinical Trial Solution Market trends, estimations, and dynamics of the market size from 2023 to 2030 to determine the most promising opportunities.
2. Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
3. In-depth analysis, as well as market size and segmentation, help you identify current AI-Based Clinical Trial Solution Market opportunities.
4. The largest countries in each region are mapped according to their revenue contribution to the market.
5. The AI-Based Clinical Trial Solution Market research report gives a thorough analysis of the current status of the AI-Based Clinical Trial Solution Market's major players.
Request for Buy Report @
https://globalmarketvision.com/checkout/?currency=USD&type=single_user_license&report_id=204771
Finally, researchers direct its focus toward the overall demand of the global AI-based clinical Trial Solution market in the forecast period. The research report offers an in-depth investigation of the global market by considering various business aspects. The essential information has been inspected for evaluation of market performance.
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Content:-
Chapter 1 Global AI-Based Clinical Trial Solution Market Overview
Chapter 2 Market Data Analysis
Chapter 3 Market Technical Data Analysis
Chapter 4 Market Government Policy and News
Chapter 5 Market Demand in 2023
Chapter 6 Market Status and Forecast 2023-2030
Chapter 7 Global AI-Based Clinical Trial Solution Market Key Vendors
Chapter 8 Up and Down Stream Industry Analysis
Chapter 9 Marketing Strategy - Market Analysis
Chapter 10 Market Development Trend Analysis
Chapter 11 Global AI-Based Clinical Trial Solution Market New Project Investment Feasibility Analysis
Get in Touch with Us
Sarah Ivans | Business Development
Phone: +1 617 297 8902
Email: sales@globalmarketvision.com
Global Market Vision
Website: www.globalmarketvision.com
About Global Market Vision
Global Market Vision consists of an ambitious team of young, experienced people who focus on the details and provide the information as per customers' needs. Information is vital in the business world, and we specialize in disseminating it. Our experts not only have in-depth expertise but can also create a comprehensive report to help you develop your own business.
With our reports, you can make important tactical business decisions with the certainty that they are based on accurate and well-founded information. Our experts can dispel any concerns or doubts about our accuracy and help you differentiate between reliable and less reliable reports, reducing the risk of making decisions. We can make your decision-making process more precise and increase the probability of success of your goals.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI-Based Clinical Trial Solution Market Predicted to Garner Revenue of USD 5.55 Bn at a CAGR of +19% by 2030 | Aicure, Antidote, Deep Lens, Saama Technologies here
News-ID: 3192494 • Views: …
More Releases from Global Market Vision
Rapid Growth in Solar Pump Market Driven by Clean Energy Demand and Government I …
[Pune, India] - [10/07/2025] - [Global Market Vision], a leading provider of market intelligence, has released its latest report on the Solar Pump Market, projecting significant growth driven by rising demand for renewable energy solutions, increasing agricultural modernization, and supportive government policies worldwide.
According to the GMV, the global solar pump market is expected to grow at a CAGR of 33%, reaching INR 60 billion by 2024. This growth is fueled…
5G in Healthcare: The Next Frontier for Innovation and Patient Care
Market Overview:
The fundamental components of healthcare could all be changed and enhanced by 5G networks. Over the past several years, the use of 5G networks in healthcare has increased, and their applications have been strengthened by advancements in robotics, IoT, and AI that will change healthcare systems into a new connected ecosystem. The main challenge faced by healthcare systems is the fastest transmission of data.
5G technology is revolutionizing the healthcare…
Dual Screen Laptops Market Size, Share, Trends, Growth Report and Forecast
The global dual-screen laptops market is witnessing steady growth, with a forecasted increase from $2.59 billion in 2023 to $3.26 billion by 2028, driven by a compound annual growth rate (CAGR) of about 5.0%. This growth is fueled by advancements in display technology, the rising demand for portable devices, and the growing popularity of dual-screen laptops among gamers, content creators, and professionals who benefit from the enhanced multitasking capabilities these…
Active & Intelligent Packaging Market Market Data and In-depth Analysis to 2032 …
Future Market Consulting Global Market Vision has published a research report on the "Global Active & Intelligent Packaging Market", which provides a comprehensive outline of the factors responsible for the market growth from 2018 to 2032. The Active & Intelligent Packaging Market value is USD XX million in 2023 and is expected to grow to USD XX million by 2032 with a CAGR of XX% during the forecast period. …
More Releases for Trial
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
